14^th World Congress on Endocrinology & Diabetes November 21-22, 2018 Paris, France

The author received an honorable PhD in mathematics and majored in engineering at MIT. He attended different universities over 17 years and studied seven academic disciplines. He has spent 20,000 hours in T2D research. First, he studied six metabolic diseases and food nutrition during 2010-2013, then conducted research during 2014-2018. His approach is “math-physics and quantitative medicine” based on mathematics, physics, engineering modeling, signal processing, computer science, big data analytics, statistics, machine learning, and AI. His main focus is on preventive medicine using prediction tools. He believes that the better the prediction, the more control you have.

Diabetes, Endocrinology, Metabolism

Irina Vladimirivna OSOKINA, M.D., Ph.D. currently working at Endocrinology Dept, Krasnoyarsk Science Centre of the Siberian Branch of Russian Academy of Science, Russia. M.D. (Pediatric Endocrinology): In November 1992 I had defended scientific research paper. The name of the thesis: "Clinical, Immunogenetic and Hormone-Metabolic Peculiarities of Insulin-Dependent Diabetes Mellitus in Early Childhood and Preschool Age". I worked in 1987-1993 under the guidance of academician Ivan.I. Dedov in the National Research Endocrinology Сenter, Russian Academy of Medical Sciences in Moscow. Ph.D. 2002. (Endocrinology). In November 2002 I had defended the Ph.D. thesis: "Epidemiological and Immunogenetic Peculiarities of Type 1 Diabetes and Iodine Deficiency Disorders in Central Siberia"in National Research Endocrinology Сenter, Russian Academy of Medical Sciences, Moscow (under the guidance of academician Ivan.I. Dedov. Now he is the President of Russian Academy of Medical Sciences) Membership of national and international societies: International Society for Pediatric and Adolescent Diabetes. International Council for Control of Iodine Deficiency Disorders. Russian Endocrinology association Russian Pediatric association Japan-Russia Medical Exchange Association She have published many articles in top renowned journals and have eminence experience in the field of Endocrinology and Diabetes.

Endocrinology, Paediatric Endocrinology, Diabetes, Thyroid Disorders.

Sharma S. Prabhakar is a distinguished nephrologist currently at Texas Tech University Health Sciences Center, where he is a tenured professor in the Departments of Medicine and Cell Physiology and Molecular Biophysics, and the Chief of Nephrology Division and Vice Chairman, Department of Medicine. He is an established researcher examining pathophysiologic mechanisms of diabetic nephropathy and of insulin resistance in vitro and animal models.Dr. Prabhakar has over 100 publications including original articles, reviews, book chapters and published abstracts in prestigious journals, such as the American Journal of Physiology, Journal of American Society of Nephrology, and Kidney International. In recognition of his excellence in practice of medicine, Dr. Prabhakar was awarded an endowed chair by the University Medical Center. He is active in several professional societies and organizations and is the current President of American Federation for Medical Research.

Professional interests include research and also educating physicians and general community in hypertension, diabetes and kidney disease.

Ralph Abraham is the Clinical Director of London Medical, which he founded as The London Diabetes & Lipid Centre in 1991. Starting his career as a biochemist at Oxford, he did a PhD in Biochemistry at Imperial College on insulin resistance in obese mice, a subject that is all too relevant in the management of diabetes today. Abraham was trained at the Hammersmith Hospital and Kings College Hospital in gastroenterology and hepatology before specialising in Endocrinology and Diabetes at St Mary\'s Hospital and St Bartholomew\'s Hospital, leaving the NHS in 1986. Dr. Abraham works in full time private practice with a successful and recognised expertise in diabetes, endocrinology, lipid disorders and obesity management.

ADVANCED DIABETES CARE INCLUDING THE USE OF SENSORS AND PUMPS PREVENTION OF HEART ATTACKS AND STROKES HORMONE PROBLEMS, ESPECIALLY THE PITUITARY AND ADRENAL GLANDS OBESITY, CHOLESTEROL DISORDERS

Dr. Christian Dani, Ph.D, is an expert in human adipose-derived stem cells and differentiation of pluripotent stem cells into adipocytes. He did a Ph.D in molecular biology in Montpellier University (France). Then, he conducted a 2-year program research on the biology of embryonic stem cells in Pr. A. Smith’s laboratory (Edindurgh, Scotland). He is now director of research at the French National Institute for Health and Medical Research (INSERM) and the director the “Stem Cells and Differentiation” laboratory at the University of Nice-Sophia Antipolis.

Diabetes, Stem Cells,etc

Guy H Fontaine has made 17 original contributions in the design and the use of the first cardiac pace makers in the early 60s. He has serendipitously identified ARVD during his contributions to antiarrhythmic surgery in the early 70s. He has developed the technique of Fulguration to replace surgery in the early 80s (technique used during 30 years in Paris). He has been one of the 216 individuals who have made a significant contribution to the study of cardiovascular disease since the 14th century, one of the 500 greatest geniuses of the 21th Century (USA Books), one of the 100 Life Time Achievement (UK Book). He has more than 900 publications including 201 chapters in text books. He is the reviewer of 26 scientific journals both in basic and clinical science. He served as a member of the Editorial Board of Circulation for 5 years, after reviewing articles for this journal during decades. He has given 11 master lectures of 90 minutes each in inland China in 2014. He has recently developed new techniques of hypothermia for brain protection in OHCA and Stroke. This technique has been fortuitously used after resuscitation of his wife at home in June 2011 with absolutely no neurologic deficit despite 6 minutes of no flow. He has also invented a high-tech device which can be considered the ultimate in palliative care by preventing unexpectedly awaking after ordinary sleep. This device was mostly designed for major neurologic disorders.

Diabetes, Antiarrhythmic surgery, Cardiovascular Disease, Cardiac Pace Makers

Dr. Mayank Singhal is a graduate from University College of Medical Sciences and currently working as an Academic Hospitalist at Cape Fear Valley Hospital, NC, USA and affiliated with Methodist University as Associate Professor of Clinical Medicine. He is also teaching faculty for Internal Medicine Residency at Campbell University School of Osteopathic Medicine, USA. He is Board Certified in American Board of Internal Medicine (ABIM). He is a member of Society of Hospital Medicine and American College of Physicians. He is also active as a Reviewer for scholarly articles and member of Editorial board for journals.

Medicine and Clinical research

Dr. Joseph Fomusi Ndisang is an Associate Professor in the University of Saskatchewan College of Medicine, Department of Physiology. He received postdoctoral training in Physiology at the University of Saskatchewan College of Medicine from 2000-2005. He obtained a PhD in Pharmacology & Toxicology from the University of Florence, Italy, 2000. He obtained a Doctor of Pharmacy degree from University of Florence, Italy in 1995. He has received several distinguished awards and distinctions including: (i) Fellow of the Canadian Cardiovascular Society (FCCS) in 2016, (ii) Fellow of the American Heart Association (FAHA) in 2011; (iii) Fellow of the International College of Angiology (FICA) in 2007; (iv) Young Investigator Award by International College of Angiology (2007); (v) Young Investigator Award by the American Society of Pharmacology & Experimental Therapeutics-Division for Drug Discovery, Development & Regulatory Affairs (2005); (vi) Young Investigator Award by the Society of Experimental Biology and Medicine (2005); (vii) Caroline tum Suden/Frances A Hellebrandt Professional Opportunity Award for Meritorious Research by the American Physiological Society (2005); and (viii) Recognition Award for Meritorious Research by a Young Investigator by the American Physiological Society (2004). Top 5% of cited authors in journals of Biology and Biochemistry in 2011, by Thomson-Reuters. Currently, Dr. Ndisang is an Editor for Frontiers in Bioscience (impact factor 3.8) and Executive Guest Editor for Current Medicinal Chemistry (impact factor 3.7) He has published more than 65 -full length manuscripts in peer-reviewed journals and more than 80 abstracts. Dr. Ndisang has served as external PhD examiner for several universities in Canada, has given more than 30-invited talks, and has also served as peer-reviewer for several reputed journals (like NEMJ) and granting agencies in United States, United Kingdom, Canada, New Zealand and Poland.

His research is mainly focused on hypertension, diabetes (types-1 and -2), and obesity.